Literature DB >> 7697536

beta-2 Microglobulin values among human immunodeficiency virus (HIV)-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans.

E M Piwowar1, S B Tugume, R M Grant, T Lutalo, K Pattishall, E Katongole-Mbidde.   

Abstract

Mean serum beta-2 microglobulin levels among healthy human immunodeficiency virus-seronegative and asymptomatic and symptomatic human immunodeficiency virus-seropositive Ugandans were found to be 2.35, 3.75, and 5.06 mg/liter, respectively (P < 0.001). The upper limit of the normal range (3.5 mg/liter) is higher in this African population than that reported elsewhere.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7697536      PMCID： PMC170135          DOI： 10.1128/cdli.2.2.236-237.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  6 in total

1.  2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.

Authors:  P L Witt; G T Spear; M J Lindstrom; H A Kessler; E C Borden; J Phair; A L Landay
Journal:  AIDS       Date:  1991-03       Impact factor: 4.177

2.  Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy.

Authors:  R L Burkes; A E Sherrod; M L Stewart; P S Gill; S Aguilar; C R Taylor; M D Krailo; A M Levine
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

Review 3.  Surrogate markers for assessing treatment response in HIV disease.

Authors:  R C Rathbun
Journal:  Ann Pharmacother       Date:  1993-04       Impact factor: 3.154

4.  Differences in laboratory values in HIV infection by sex, race, and risk group.

Authors:  R W Gorter; K M Vranizan; D H Osmond; A R Moss
Journal:  AIDS       Date:  1992-11       Impact factor: 4.177

5.  Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.

Authors:  R E Anderson; W Lang; S Shiboski; R Royce; N Jewell; W Winkelstein
Journal:  Arch Intern Med       Date:  1990-01
  6 in total
  6 in total

1.  BETA-2-MICROGLOBULIN LEVELS IN HUMAN-IMMUNODEFICIENCY VIRUS INFECTED SUBJECTS.

Authors:  Mkk Rao; S K Sayal; S S Uppal; R M Gupta; V C Ohri; S Banerjee
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers.

Authors:  Hong-Ha M Truong; Myung S Sim; Maryanne Dillon; Christel H Uittenbogaart; Ruth Dickover; Susan F Plaeger; Yvonne J Bryson
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

3.  Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay.

Authors:  R M Grant; E M Piwowar; E Katongole-Mbidde; W Muzawalu; S Rugera; J Abima; S L Stramer; P Kataaha; B Jackson
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

4.  Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?

Authors:  Samuel Nyamweya; John Townend; Akram Zaman; Sarah Jane Steele; David Jeffries; Sarah Rowland-Jones; Hilton Whittle; Katie L Flanagan; Assan Jaye
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

5.  An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.

Authors:  Maneesh Singh; Pratibha Singh; Gilles Gaudray; Lucia Musumeci; Caroline Thielen; Dolores Vaira; Claire Vandergeeten; Laurence Delacroix; Ellen Van Gulck; Guido Vanham; Laurence de Leval; Souad Rahmouni; Michel Moutschen
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

6.  Gender and HIV-associated pulmonary tuberculosis: presentation and outcome at one year after beginning antituberculosis treatment in Uganda.

Authors:  Peter Nsubuga; John L Johnson; Alphonse Okwera; Roy D Mugerwa; Jerrold J Ellner; Christopher C Whalen
Journal:  BMC Pulm Med       Date:  2002-09-11       Impact factor: 3.317
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.